Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity.

Jeanne A, Sarazin T, Charlé M, Moali C, Fichel C, Boulagnon-Rombi C, Callewaert M, Andry MC, Diesis E, Delolme F, Rioult D, Dedieu S

Open source

DOI
10.3390/cancers13195019
Published
2021 Oct 7
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers13195019,
  title = {Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity.},
  author = {Jeanne A and Sarazin T and Charlé M and Moali C and Fichel C and Boulagnon-Rombi C and Callewaert M and Andry MC and Diesis E and Delolme F and Rioult D and Dedieu S},
  year = {2021},
  journal = {Cancers},
  doi = {10.3390/cancers13195019},
  url = {https://doi.org/10.3390/cancers13195019}
}

RIS

TY  - JOUR
TI  - Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity.
AU  - Jeanne A
AU  - Sarazin T
AU  - Charlé M
AU  - Moali C
AU  - Fichel C
AU  - Boulagnon-Rombi C
AU  - Callewaert M
AU  - Andry MC
AU  - Diesis E
AU  - Delolme F
AU  - Rioult D
AU  - Dedieu S
PY  - 2021
JO  - Cancers
DO  - 10.3390/cancers13195019
UR  - https://doi.org/10.3390/cancers13195019
ER  - 

APA

A, J., T, S., M, C., C, M., C, F., C, B., M, C., MC, A., E, D., F, D., D, R., & S, D. (2021). Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity.. Cancers. https://doi.org/10.3390/cancers13195019

Source records